The University of Texas - MD Anderson Cancer Center — Houston, Texas

Public research footprint of The University of Texas - MD Anderson Cancer Center, compiled from the ClinicalTrials.gov public registry.

711

Registered studies

281

Active

181

Recruiting now

252

Completed

154

Stopped or withdrawn

Most-studied conditions

Solid Tumors · Post- Essential Thrombocythemia Myelofibrosis · Low Grade Upper Tract Urothelial Carcinoma · Metastatic Non-Small-Cell Lung Cancer

Recently updated registry entries

NCT06160752 — Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating… (Active Not Recruiting)
NCT07594106 — REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in… (Recruiting)
NCT07306559 — A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Texas - MD Anderson Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.